Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Germany Plans Beyond Corona With Investment In Health Care And Digital

Executive Summary

Better health care infrastsructures, enhanced digital capabilities and temporary VAT cuts are part the German coalition government’s new investment plan to revive the economy in aftermath of COVID-19.

You may also be interested in...



Glooko Raises $30M To Accelerate Commercial Strategy, R&D, Tuck-In Acquisitions

Glooko will use the proceeds to expand into new geographies and take advantage of rising reimbursement for digital health, expand solutions for co-morbid conditions, and explore tuck-in acquisitions.

Germany’s ‘Future Hospitals’ Draft Law Needs Sharp Focus On Digital And Robotics Investment

Hospital administrators and clinicians in Germany seek enhanced digitization of clinical procedures, but the budgets have not always been available. A new “future hospitals investment” program, now made into a draft law, should reserve funds for robotics and digital health care.

UK Medtech Strategy Promises To Use Innovation Effectively And Build Resilience

The UK MedTech Directorate has issued its much-awaited medical technology strategy for improving supply resilience and encouraging innovative and dynamic markets and sector diversity.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT142266

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel